Peptide Drug Discovery Platform
Drugging the undruggable
Peptides as a therapeutic method attract much attention due to the synthetic accessibility, high degree of specific binding, and the ability to target protein surfaces traditionally considered "undruggable". Macrocyclic peptides possess a lot of pharmacological characteristics distinct from other well-established therapeutic molecular classes, resulting in a versatile drug modality with a unique profile of advantages.
Medicilon's peptide drug discovery service team comprises 60 chemists and 15 biologists skilled in Solid Phase Synthesis, Solution Phase Synthesis, Synthetic Biology Synthesis and Purification & QC.